A Registry Study on Rimegepant for the Treatment of Migraine Participants in Guangdong-Hong Kong-Macao Greater Bay Area

RecruitingOBSERVATIONAL

Enrollment

120

Participants

Timeline

Start Date

January 26, 2024

Primary Completion Date

May 31, 2024

Study Completion Date

June 30, 2024

Conditions

Migraine

Interventions

DRUG

Rimegepant

No intervention. The study will record the usage, timing, frequency, and dosage of rimegepant in a real-world clinical setting.

Trial Locations (1)

RECRUITING

Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou

All Listed Sponsors

lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER